SCHEMBL20180516

SCHEMBL20180516

CC(=O)[C@H]1CC[C@H](CN2C(=O)C[C@@H](C)C2=O)CC1

nearest known ligand 0.40

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.34
GPBAR1 Q8TDU6 1/20 0.32
ALDH1A1 P00352 1/20 0.32
FKBP1A P62942 1/20 0.31
BACE1 P56817 1/20 0.31
BACE2 Q9Y5Z0 1/20 0.31
LMNA P02545 1/20 0.30
MT-CO2 P00403 1/20 0.30
ALOX5 P09917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20180680 1.00 HTT (0.34) HTTGPBAR1ALDH1A1FKBP1ABACE1
SCHEMBL23369279 1.00 HTT (0.34) HTTGPBAR1ALDH1A1FKBP1ABACE1
SCHEMBL12013341 1.00 HTT (0.34) HTTGPBAR1ALDH1A1FKBP1ABACE1
SCHEMBL20180664 1.00 HTT (0.34) HTTGPBAR1ALDH1A1FKBP1ABACE1
SCHEMBL19533069 1.00 HTT (0.34) HTTGPBAR1ALDH1A1FKBP1ABACE1
SCHEMBL26755735 0.87 ACHE (0.32) ALDH1A1FKBP1A
SCHEMBL19245754 0.86 GPBAR1 (0.31) GPBAR1ALDH1A1BACE1BACE2
SCHEMBL21126773 0.86 GPBAR1 (0.31) GPBAR1ALDH1A1BACE1BACE2
SCHEMBL17570992 0.86 ALDH1A1 (0.33) GPBAR1ALDH1A1BACE1BACE2
SCHEMBL24952144 0.86 GPBAR1 (0.31) GPBAR1ALDH1A1BACE1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022087243-A1 ANTI-FGFR2 ANTIBODIES AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2022-04-28 WO disclosed
WO-2019217591-A1 ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2019-11-14 WO disclosed
WO-2018093866-A1 ANTI-MET ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND MET, AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2018-05-24 WO disclosed